National vaccine program key driver in reduced COVID cases: Study Real-world data has added further weight to the potential public health benefits of mass-vaccination against the coronavirus.
Vaccine rollout funding reform headlines RACGP advocacy agenda The college continues to call for additional MBS item numbers to support vaccine counselling in general practice.
Australians ‘highly concerned’ about COVID vaccine side effects Though there has been a recent uptick in people who say they would get a ‘safe and effective’ vaccine, according to a new survey.
GPs’ AstraZeneca supply to be increased immediately Practices will now receive an additional 150–200 doses each week.
Promise wanes for mRNA onshore production With local manufacturing of mRNA vaccines looking increasingly slim in the short term, where does that leave Australia?
AstraZeneca and Pfizer: What are the side effects of Australia’s vaccines? People under 55, women and those previously infected with COVID-19 are more likely to report side effects after receiving either vaccine, according to new research.
Over-50s can now get their COVID vaccine: What do they need to know? Amid reports of blood clots and increasing vaccine hesitancy, patients will likely have questions as the next phase of the rollout gets underway.
GPs with AstraZeneca stockpile turn attention to vaccinating over-50s Patient concerns around the AstraZeneca vaccine have seen a decline in interest in some practices, prompting GPs to bring forward the new rollout strategy’s commencement date.
Numbers confirm GPs are the ‘backbone’ of COVID vaccine rollout Australia’s GPs have now administered more than 1.05 million vaccine doses – more than half the rollout’s total of 2.03 million.
Benefits of AstraZeneca overwhelmingly high despite increased clotting risk New European research has found the risk of a rare blood clotting syndrome associated with the vaccine is double what has been previously reported.